Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.35M$3.35Mderived+6,953.7% vs Q4 2018 Net Income-$1.46M-$1.46MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,053,129+12,151.7% Operating Incomederived-$1,462,561N/M Operating Cash Flowderived-$833,523N/M Free Cash Flowderived-$849,089N/M Margins · derivedGross margin91.1%+38.6 pt vs Q4 2018
Operating margin-43.6%+939.9 pt vs Q4 2018
Net margin-43.6%+980.7 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 26, 2020 · 86 d after period end